Ejection fraction

Ejection fraction (EF) is a measurement that tells us what percentage of blood leaves the heart with each beat. Specifically, it compares the amount of blood that exits the heart's main pumping chamber (the left ventricle) to the total amount of blood that chamber holds when full. A healthy heart typically ejects between 50-70% of its blood volume with each contraction. Think of it as a measure of how efficiently your heart is doing its job as a pump.

Ejection fraction is a cornerstone concept in cardiology and is used to diagnose and monitor heart disease, particularly heart failure. Cardiologists measure it using imaging techniques like echocardiography, MRI, or nuclear scans to assess whether a patient's heart is weakened or functioning normally. The concept matters because a low ejection fraction indicates the heart isn't pumping effectively, which can lead to serious health consequences including fluid buildup in the lungs, fatigue, and organ damage.

To understand how ejection fraction works, imagine a syringe filled with water: when you pull back the plunger, it fills completely (this is the heart's relaxation phase), and when you push it forward, some water squirts out (this is the contraction phase). The ejection fraction is the percentage of water that exits compared to the total volume that was in the syringe. If your syringe is damaged or weak, it won't push out as much water—similarly, a weakened heart won't eject as high a percentage of blood, resulting in a lower ejection fraction.

Ejection fraction is critical for modern cardiology because it guides treatment decisions and predicts patient outcomes in heart failure and other cardiac conditions. Researchers use changes in ejection fraction to evaluate whether new therapies are working, and patients with persistently low ejection fractions may require advanced interventions like implantable devices or heart transplantation. Understanding and improving ejection fraction remains central to developing better treatments for the millions of people living with heart disease worldwide.